← All stock verdicts

Stock verdict · Screened September 2026

Is Nutrien (NTR) Halal?

Verdict: No — Nutrien fails Shariah screening as of September 2026. The business (crop inputs) is perfectly fine; the balance sheet is not. Debt sits at ~33.1% of market cap on a spot basis and ~35–40% on the trailing-average basis the methodologies actually use — against a 33% ceiling. Zoya and Musaffa independently agree. Below: the full screening math, the close-call nuance, and what to hold instead.

FAIL
Non-compliant (September 2026). Fails the debt-ratio screen: ~33–40% total debt to market cap against the 33% ceiling (methodology-standard trailing-average basis). The business itself is halal. This is a screening result, not a fatwa.

Screen 1: Business activity — passes

Nutrien is a Saskatoon-based crop-input provider: six potash mines, nitrogen and phosphate production, and the world's largest agricultural retail network (Nutrien Ag Solutions, ~1,900 locations across seven countries). Nothing in the core business touches prohibited industries — no alcohol, gambling, pork, weapons, banking, insurance, or entertainment.

One flag to disclose: Nutrien Financial, a captive unit inside the Retail segment, earns "interest and service fees" on extended payment terms to farmers — about C$97M externally, roughly 0.9% of revenue. That is ancillary interest income, not a core business, so it clears the business screen but the purification screen applies to that slice. The business screen passes.

Screen 2: Financial ratios — where it fails

AAOIFI-style screening applies three ratio tests:

RatioNutrien (Sept 2026)CeilingResult
Total debt ÷ market cap≈33–40% ($11,388M debt on ~$34.4B market cap; ~39.7% on mid-Aug data)< 33%FAIL
Cash + interest-bearing securities ÷ market cap≈ 2.7% ($921M cash)< 33%PASS
Non-compliant income ÷ total revenue≈ 0.9% (~$97M Nutrien Financial interest/service fees on $10,812M Q2 2026 sales)< 5%PASS

Figures in USD: Q2 2026 (quarter ended June 30, 2026) for debt, cash, and revenue; market data September 28, 2026 (~477.21M shares × $72.04 NYSE). The spot ratio is ~33.1% — knife's-edge — but AAOIFI/DJIM methodologies use trailing-average market capitalization, on which basis the ratio sits clearly above the ceiling (~35–40%). The verdict is robust on the methodology-standard basis; we've stated both so you can see the working.

This is structural, not a one-quarter blip. Nutrien carries heavy debt from its potash-expansion and retail build-out, and the ratio has sat at or above the ceiling on a trailing basis. For the debt screen to pass, Nutrien would need to pay down several billion in debt or see its market cap recover materially without adding leverage.

Why the close call still fails. A spot ratio of ~33.1% looks like a rounding error — but the methodologies don't use spot market caps precisely to avoid this game. AAOIFI and Dow Jones Islamic Market average market capitalization over trailing periods, and on that basis Nutrien is clearly over. Zoya and Musaffa both independently rate NTR non-compliant as of September 2026, and the math agrees.

Screen 3: Purification — doesn't apply

Purification is for compliant holdings that earn small, incidental amounts of non-compliant income. It does not apply to a non-compliant holding: you don't purify a prohibited position, you don't hold it. Nutrien's dividend — and its ~0.9% Nutrien Financial interest slice — can't be "purified" into permissibility.

"But it's just fertilizer…"

This is the real reason the question gets asked. Nutrien's business is about as wholesome as it gets — feeding the world — and it's a fixture of Canadian dividend portfolios. The screening answer doesn't dispute any of that; it just points out that the screen has two gates, and the balance sheet, not the business, is what fails here. A clean business funded with too much debt doesn't become halal because the product is virtuous.

What to hold instead

If Nutrien was your Canadian materials/income anchor, the halal replacements aren't another leveraged producer — they're screened equities and halal ETFs:

What could change the verdict

A genuine, sustained deleveraging — Nutrien paying down several billion in debt — or a durable market-cap recovery without new borrowing. Because the spot ratio sits right at the line, this is the one FAIL verdict most likely to flip on re-screening; we check quarterly and will update this page the moment the trailing-average ratio clears 33%.

FAQ

Is Nutrien halal to invest in?

As of September 2026: no. Nutrien's business (crop inputs) is fine, but its debt ratio sits at or above the 33% ceiling — ~33.1% on spot market cap, ~35–40% on the trailing-average basis the methodologies use. Zoya and Musaffa independently rate NTR non-compliant. This is a screening result, not a religious ruling.

It's just fertilizer — why does it fail?

The business passes; the balance sheet fails. Shariah screening has two independent gates: a prohibited-industry check and financial-ratio checks. Nutrien clears the first but carries ~$11.4B in debt against a ~$34.4B market cap. Both gates must pass.

The debt ratio is right at 33% — is this a close call?

On today's spot market cap, yes — ~33.1%. But AAOIFI/DJIM methodologies average market cap over trailing periods specifically to prevent timing games, and on that basis Nutrien is clearly over (~35–40%). The verdict is robust on the methodology-standard basis, and we've published both numbers.

What about Nutrien Financial's interest income?

Nutrien Financial earns interest and service fees on extended farmer payment terms — about $97M externally, ~0.9% of revenue. That's ancillary income, not a core business, so it doesn't fail the business screen — but it would require purification if the stock were compliant. Since the stock fails on debt, the point is moot.

Can I purify Nutrien's dividends and keep holding?

No — purification applies to compliant holdings with incidental non-compliant income, not to non-compliant holdings. The standard guidance for a stock that fails screening is not to hold it.

I already own NTR shares. What should I do?

The common guidance in screening methodologies is to exit the position. Scholars differ on timing — immediately vs. waiting to avoid a loss — and on how to handle dividends already received. Those are personal-ruling questions for a qualified scholar, not for a website. Don't offset other gains against the position, and re-screen whatever you replace it with.

Affiliate disclosure. This page contains no affiliate links, and the site currently earns no affiliate revenue; commissions never influence our scores or rankings, and every product is Shariah-screened before review. Nothing on this site is financial advice — facts and screening methodology only, no fatwas.